Leicher Brian, Day Ellen, Colonias Athanasios, Gayou Olivier
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA.
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA.
Med Dosim. 2014 Autumn;39(3):272-5. doi: 10.1016/j.meddos.2014.05.001. Epub 2014 Jun 7.
To describe a dosimetric method using an anterior dose avoidance structure (ADAS) during the treatment planning process for intensity-modulated radiation therapy (IMRT) for patients with anal canal and rectal carcinomas. A total of 20 patients were planned on the Elekta/CMS XiO treatment planning system, version 4.5.1 (Maryland Heights MO) with a superposition algorithm. For each patient, 2 plans were created: one employing an ADAS (ADAS plan) and the other replanned without an ADAS (non-ADAS plan). The ADAS was defined to occupy the volume between the inguinal nodes and primary target providing a single organ at risk that is completely outside of the target volume. Each plan used the same beam parameters and was analyzed by comparing target coverage, overall plan dose conformity using a conformity number (CN) equation, bowel dose-volume histograms, and the number of segments, daily treatment duration, and global maximum dose. The ADAS and non-ADAS plans were equivalent in target coverage, mean global maximum dose, and sparing of small bowel in low-dose regions (5, 10, 15, and 20 Gy). The mean difference between the CN value for the non-ADAS plans and ADAS plans was 0.04 ± 0.03 (p < 0.001). The mean difference in the number of segments was 15.7 ± 12.7 (p < 0.001) in favor of ADAS plans. The ADAS plan delivery time was shorter by 2.0 ± 1.5 minutes (p < 0.001) than the non-ADAS one. The ADAS has proven to be a powerful tool when planning rectal and anal canal IMRT cases with critical structures partially contained inside the target volume.
描述一种在肛管和直肠癌患者调强放射治疗(IMRT)治疗计划过程中使用前向剂量规避结构(ADAS)的剂量测定方法。共有20例患者在Elekta/CMS XiO治疗计划系统(版本4.5.1,马里兰州高地市)上进行计划,采用叠加算法。对于每位患者,创建了2个计划:一个采用ADAS(ADAS计划),另一个在没有ADAS的情况下重新计划(非ADAS计划)。ADAS被定义为占据腹股沟淋巴结和主要靶区之间的体积,提供一个完全位于靶区体积之外的单一危及器官。每个计划使用相同的射束参数,并通过比较靶区覆盖情况、使用适形数(CN)方程的总体计划剂量适形性、肠剂量体积直方图以及射野分段数、每日治疗时长和总体最大剂量进行分析。ADAS计划和非ADAS计划在靶区覆盖、平均总体最大剂量以及低剂量区域(5、10、15和20 Gy)小肠的 sparing方面相当。非ADAS计划和ADAS计划的CN值平均差异为0.04±0.03(p<0.001)。射野分段数的平均差异为15.7±12.7(p<0.001),有利于ADAS计划。ADAS计划的执行时间比非ADAS计划短2.0±1.5分钟(p<0.001)。当计划靶区内部分包含关键结构的直肠和肛管IMRT病例时,ADAS已被证明是一个强大的工具。